Roche Holding AG (RHHBY)
29.83
+0.57
(+1.95%)
USD |
OTCM |
May 03, 16:00
Roche Cash from Operations (TTM): 18.04B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 18.04B |
June 30, 2023 | 17.76B |
December 31, 2022 | 18.47B |
June 30, 2022 | 23.35B |
December 31, 2021 | 22.86B |
June 30, 2021 | 21.75B |
December 31, 2020 | 20.06B |
June 30, 2020 | 21.74B |
December 31, 2019 | 22.51B |
June 30, 2019 | 20.06B |
December 31, 2018 | 20.15B |
June 30, 2018 | 18.53B |
December 31, 2017 | 18.27B |
June 30, 2017 | 17.24B |
December 31, 2016 | 15.16B |
June 30, 2016 | 14.60B |
December 31, 2015 | 15.73B |
June 30, 2015 | 15.61B |
Date | Value |
---|---|
December 31, 2014 | 17.18B |
June 30, 2014 | 18.28B |
December 31, 2013 | 17.14B |
June 30, 2013 | 16.19B |
December 31, 2012 | 16.08B |
June 30, 2012 | 14.34B |
December 31, 2011 | 14.55B |
June 30, 2011 | 15.87B |
December 31, 2010 | 13.95B |
June 30, 2010 | 14.99B |
December 31, 2009 | 16.10B |
June 30, 2009 | 13.11B |
December 31, 2008 | 11.03B |
June 30, 2008 | 10.63B |
December 31, 2007 | 9.971B |
June 30, 2007 | 8.957B |
December 31, 2006 | 8.345B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
17.76B
Minimum
Jun 2023
23.35B
Maximum
Jun 2022
20.66B
Average
20.90B
Median
Cash from Operations (TTM) Benchmarks
Novartis AG | 13.77B |
Pfizer Inc | 8.70B |
ADC Therapeutics SA | -118.69M |
Lonza Group Ltd | 1.560B |
AC Immune SA | -67.27M |